<DOC>
	<DOCNO>NCT02043522</DOCNO>
	<brief_summary>This study do radioisotope , 123I-mIBG ( Adreview ) , develop nuclear diagnostic image test patient decrease heart function use predict progression heart disease provide appropriate clinical treatment . The type patient study include patient heart attack heart muscle may damage patient diagnosed heart failure enlarge heart . Both condition may cause poor muscle contraction disturbance electrical signal conduction . There also control group participant evidence heart disease . 123I-mIBG show effective assess area heart activate involuntarily sympathetic nervous system ( SNS ) . 123I-mIBG iodine base radioisotope chemically similar norepinephrine ( NE ) heart . NE responsible way SNS regulate heart function heart rate force heart contraction . NE act automatically maintain homeostasis balance within SNS . The amount 123I-mIBG , mimic NE , appear nuclear image use heart-to-mediastinum ratio ( H/M ratio ) , predictive progression heart failure , arrhythmia ( irregular heartbeat ) cardiac death . Two different type single photon emission compute tomography ( SPECT ) image use : standard SPECT cadmium-zinc-telluride ( CZT ) SPECT . The investigator hypothesize CZT SPECT great H/M ratio standard SPECT imaging .</brief_summary>
	<brief_title>123I-mIBG SPECT Imaging</brief_title>
	<detailed_description>123I-mIBG ( MIBG ) cardiac scintigraphy use assess cardiac sympathetic activity predict prognosis patient heart failure . The result prognostic study validate AdreView Myocardial Imaging Risk Evaluation Heart Failure ( ADMIRE-HF ) trial , large multi-centre prospective international study 961 patient NYHA Class II - III Heart Failure LV ejection fraction &gt; 35 % 2 . This landmark study use planar image calculation heart-to-mediastinal ratio ( H/M ) quantitative analysis global uptake . The H/M 4 hour delay planar image predictive heart failure progression , arrhythmic event cardiac death provide incremental value B-type natriuretic peptide leave ventricular ( LV ) ejection fraction . In study use quantitative MIBG SPECT , new method calculation H/M ratio develop , compare several reconstruction method demonstrate H/M ratio SPECT equivalent planar H/M ratio differentiate normal participant heart failure patient . The ability SPECT image provide accurate quantitative measurement myocardial activity may also provide accurate measurement MIBG washout , show predictive sudden cardiac death use planar imaging . SPECT image also provide information regional distribution MIBG , demonstrate predictive sudden cardiac death . Similarly , mismatch regional MIBG uptake perfusion reflect deinnervation viable tissue may identify myocardium potential development ventricular arrhythmia . Thus , SPECT MIBG imaging may provide much useful prognostic information addition H/M ratio . Participants single dose isotope H/M ratio measure use 3 type image technique camera software currently use University Ottawa Heart Institute : 1 . Planar ( 2D ) imaging , use ADMIRE-HF trial 2 . Hawkeye Infinia 3D SPECT imaging , conventional SPECT 3 . Discovery NM-530 CZT 3D SPECT imaging , new SPECT technology Images take predetermine time point 5 hour period study /injection day . Participants monitor clinical change routine lab work physical observation study .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>For participant : 1 . Male female â‰¥ 18 year study entry . 2 . Able willing comply study procedure . 3 . Written informed consent . 4 . Female subject must postmenopausal , surgically sterilize negative serum beta human chorionic gonadotropin pregnancy test initial screen maintain effective contraceptive method throughout trial 30 day follow end dosing . For participant coronary artery disease document myocardial infarction : 5 . Diagnosis coronary artery disease ( CAD ) base one following : document myocardial infarction , significant obstructive CAD invasive compute tomography ( CT ) coronary angiography abnormal stress perfusion study consistent ischemia scar 6 . LV ejection fraction &gt; 40 % noninvasive imaging invasive LV angiography . 7 . NYHA Class 0 , I II heart failure symptom . For participant nonischemic cardiomyopathy LV ejection fraction 30 40 % : 5 . Diagnosis NYHA Class II III heart failure . 6 . No evidence significant obstructive CAD invasive coronary angiography noninvasive stress image 7 . Resting LV ejection fraction &lt; 40 % noninvasive imaging within 30 day research cardiac MIBG image 8 . Current stable treatment regimen medication include betablocker either ACE inhibitor ARB unless document intolerant class drug . 9 . Clinically stable least 7 day prior enrollment study time cardiac MIBG imaging . For control participant : 5 . Low likelihood CAD normal stress myocardial perfusion study stress echocardiogram within 6 month study entry . 6 . No significant CAD : define stenosis &gt; 30 % narrow invasive CT coronary angiography within 6 month study entry . 1 . Previously receive 123ImIBG 131ImIBG . 2 . Participation investigational product medical device study within 30 day enrollment . 3 . History suspicion significant allergic reaction anaphylaxis iodine iodinate imaging agent . 4 . Poorly control hypertension ( &gt; 180 mmHg systolic &gt; 110 mmHg diastolic ) base measurement make precede 6 month . 5 . Use medication noncardiac medical condition know interfere 123ImIBG uptake medication safely withhold least 24 hour study procedure . 6 . Cardiac revascularization , insertion ICD acute myocardial infarction within past 30 day . 7 . Serious noncardiac medical condition associate significant elevation plasma catecholamine include pheochromocytoma . 8 . Claustrophobia movement disorder prevent participant lying still supine position hour time . 9 . Renal insufficiency ( serum creatinine &gt; 3.0 mg/dL &gt; 265 mmol/L ) . 10 . Diagnosis sign symptoms neurologic disease Parkinson 's disease , multiple system atrophy Parkinsonian syndrome , disease know affect sympathetic nervous system . 11 . Breastfeeding pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>123I-mIBG</keyword>
	<keyword>SPECT Imaging</keyword>
	<keyword>Phantom imaging</keyword>
	<keyword>Heart failure</keyword>
	<keyword>Coronary artery disease</keyword>
	<keyword>Heart mediastinum ratio</keyword>
	<keyword>heart calibration ratio</keyword>
	<keyword>Myocardial blood flow</keyword>
	<keyword>Myocardial blood flow researve</keyword>
</DOC>